GATA4 and cardiac hypertrophy: GATA-4 binding sites are thought to be required for activation of β-MHC and angiotensin II type a receptor expression - both of which have been implicated in pathological ventricular hypertrophy [39] and the over expression of GATA-4 generated cardiac hypertrophy in cultured cardiomyocytes and in mice.